These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35269546)

  • 1. Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease.
    Pinto RS; Minanni CA; de Araújo Lira AL; Passarelli M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased liver AGEs induce hepatic injury mediated through an OST48 pathway.
    Zhuang A; Yap FY; Bruce C; Leung C; Plan MR; Sullivan MA; Herath C; McCarthy D; Sourris KC; Kantharidis P; Coughlan MT; Febbraio MA; Hodson MP; Watt MJ; Angus P; Schulz BL; Forbes JM
    Sci Rep; 2017 Sep; 7(1):12292. PubMed ID: 28947796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
    Yamagishi SI
    Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
    Pertynska-Marczewska M; Merhi Z
    Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.
    Lee J; Yun JS; Ko SH
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.
    Deluyker D; Evens L; Bito V
    Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis.
    Pinto RS; Machado UF; Passarelli M
    Biomark Med; 2020 Jun; 14(8):611-614. PubMed ID: 32530293
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P
    Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease.
    Yubero-Serrano EM; Pérez-Martínez P
    Angiology; 2020 Sep; 71(8):698-700. PubMed ID: 32242451
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
    Prasad K; Tiwari S
    Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
    Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
    Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose-induced AGEs-RAGE signaling in skeletal muscle contributes to impairment of glucose homeostasis.
    Rai AK; Jaiswal N; Maurya CK; Sharma A; Ahmad I; Ahmad S; Gupta AP; Gayen JR; Tamrakar AK
    J Nutr Biochem; 2019 Sep; 71():35-44. PubMed ID: 31272030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives.
    Liu J; Pan S; Wang X; Liu Z; Zhang Y
    Eur J Med Res; 2023 Dec; 28(1):553. PubMed ID: 38042909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products.
    Sahi AK; Verma P; Varshney N; Gundu S; Mahto SK
    Appl Biochem Biotechnol; 2022 Jun; 194(6):2831-2855. PubMed ID: 35257316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
    Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
    Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS.
    Azhary JMK; Harada M; Kunitomi C; Kusamoto A; Takahashi N; Nose E; Oi N; Wada-Hiraike O; Urata Y; Hirata T; Hirota Y; Koga K; Fujii T; Osuga Y
    Endocrinology; 2020 Feb; 161(2):. PubMed ID: 32020188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.